Cargando…

Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus

INTRODUCTION: PET imaging of amyloid-β (Aβ) in vivo holds promise for aiding in earlier diagnosis and intervention in Alzheimer’s disease (AD) and mild cognitive impairment. AD-like Aβ pathology is a common comorbidity in patients with idiopathic normal pressure hydrocephalus (iNPH). Fifty patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Leinonen, Ville, Rinne, Juha O, Wong, Dean F, Wolk, David A, Trojanowski, John Q, Sherwin, Paul F, Smith, Adrian, Heurling, Kerstin, Su, Mandy, Grachev, Igor D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003513/
https://www.ncbi.nlm.nih.gov/pubmed/24755237
http://dx.doi.org/10.1186/2051-5960-2-46
_version_ 1782313856008192000
author Leinonen, Ville
Rinne, Juha O
Wong, Dean F
Wolk, David A
Trojanowski, John Q
Sherwin, Paul F
Smith, Adrian
Heurling, Kerstin
Su, Mandy
Grachev, Igor D
author_facet Leinonen, Ville
Rinne, Juha O
Wong, Dean F
Wolk, David A
Trojanowski, John Q
Sherwin, Paul F
Smith, Adrian
Heurling, Kerstin
Su, Mandy
Grachev, Igor D
author_sort Leinonen, Ville
collection PubMed
description INTRODUCTION: PET imaging of amyloid-β (Aβ) in vivo holds promise for aiding in earlier diagnosis and intervention in Alzheimer’s disease (AD) and mild cognitive impairment. AD-like Aβ pathology is a common comorbidity in patients with idiopathic normal pressure hydrocephalus (iNPH). Fifty patients with iNPH needing ventriculo-peritoneal shunting or intracranial pressure monitoring underwent [(18)F]flutemetamol PET before (N = 28) or after (N = 22) surgery. Cortical uptake of [(18)F]flutemetamol was assessed visually by blinded reviewers, and also quantitatively via standard uptake value ratio (SUVR) in specific neocortical regions in relation to either cerebellum or pons reference region: the cerebral cortex of (prospective studies) or surrounding (retrospective studies) the biopsy site, the contralateral homolog, and a calculated composite brain measure. Aβ pathology in the biopsy specimen (standard of truth [SoT]) was measured using Bielschowsky silver and thioflavin S plaque scores, percentage area of grey matter positive for monoclonal antibody to Aβ (4G8), and overall pathology impression. We set out to find (1) which pair(s) of PET SUVR and pathology SoT endpoints matched best, (2) whether quantitative measures of [(18)F]flutemetamol PET were better for predicting the pathology outcome than blinded image examination (BIE), and (3) whether there was a better match between PET image findings in retrospective vs. prospective studies. RESULTS: Of the 24 possible endpoint/SoT combinations, the one with composite-cerebellum SUVR and SoT based on overall pathology had the highest Youden index (1.000), receiver operating characteristic area under the curve (1.000), sensitivity (1.000), specificity (1.000), and sum of sensitivity and specificity for the pooled data as well as for the retrospective and prospective studies separately (2.00, for all 3). The BIE sum of sensitivity and specificity, comparable to that for quantitation, was highest using Bielschowsky silver as SoT for all SUVRs (ipsilateral, contralateral, and composite, for both reference regions). The composite SUVR had a 100% positive predictive value (both reference regions) for the overall pathology diagnosis. All SUVRs had a 100% negative predictive value for the Bielschowsky silver result. CONCLUSION: Bielschowsky silver stain and overall pathology judgment showed the strongest associations with imaging results.
format Online
Article
Text
id pubmed-4003513
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40035132014-04-30 Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus Leinonen, Ville Rinne, Juha O Wong, Dean F Wolk, David A Trojanowski, John Q Sherwin, Paul F Smith, Adrian Heurling, Kerstin Su, Mandy Grachev, Igor D Acta Neuropathol Commun Research INTRODUCTION: PET imaging of amyloid-β (Aβ) in vivo holds promise for aiding in earlier diagnosis and intervention in Alzheimer’s disease (AD) and mild cognitive impairment. AD-like Aβ pathology is a common comorbidity in patients with idiopathic normal pressure hydrocephalus (iNPH). Fifty patients with iNPH needing ventriculo-peritoneal shunting or intracranial pressure monitoring underwent [(18)F]flutemetamol PET before (N = 28) or after (N = 22) surgery. Cortical uptake of [(18)F]flutemetamol was assessed visually by blinded reviewers, and also quantitatively via standard uptake value ratio (SUVR) in specific neocortical regions in relation to either cerebellum or pons reference region: the cerebral cortex of (prospective studies) or surrounding (retrospective studies) the biopsy site, the contralateral homolog, and a calculated composite brain measure. Aβ pathology in the biopsy specimen (standard of truth [SoT]) was measured using Bielschowsky silver and thioflavin S plaque scores, percentage area of grey matter positive for monoclonal antibody to Aβ (4G8), and overall pathology impression. We set out to find (1) which pair(s) of PET SUVR and pathology SoT endpoints matched best, (2) whether quantitative measures of [(18)F]flutemetamol PET were better for predicting the pathology outcome than blinded image examination (BIE), and (3) whether there was a better match between PET image findings in retrospective vs. prospective studies. RESULTS: Of the 24 possible endpoint/SoT combinations, the one with composite-cerebellum SUVR and SoT based on overall pathology had the highest Youden index (1.000), receiver operating characteristic area under the curve (1.000), sensitivity (1.000), specificity (1.000), and sum of sensitivity and specificity for the pooled data as well as for the retrospective and prospective studies separately (2.00, for all 3). The BIE sum of sensitivity and specificity, comparable to that for quantitation, was highest using Bielschowsky silver as SoT for all SUVRs (ipsilateral, contralateral, and composite, for both reference regions). The composite SUVR had a 100% positive predictive value (both reference regions) for the overall pathology diagnosis. All SUVRs had a 100% negative predictive value for the Bielschowsky silver result. CONCLUSION: Bielschowsky silver stain and overall pathology judgment showed the strongest associations with imaging results. BioMed Central 2014-04-22 /pmc/articles/PMC4003513/ /pubmed/24755237 http://dx.doi.org/10.1186/2051-5960-2-46 Text en Copyright © 2014 Leinonen et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Leinonen, Ville
Rinne, Juha O
Wong, Dean F
Wolk, David A
Trojanowski, John Q
Sherwin, Paul F
Smith, Adrian
Heurling, Kerstin
Su, Mandy
Grachev, Igor D
Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus
title Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus
title_full Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus
title_fullStr Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus
title_full_unstemmed Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus
title_short Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus
title_sort diagnostic effectiveness of quantitative [(18)f]flutemetamol pet imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003513/
https://www.ncbi.nlm.nih.gov/pubmed/24755237
http://dx.doi.org/10.1186/2051-5960-2-46
work_keys_str_mv AT leinonenville diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus
AT rinnejuhao diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus
AT wongdeanf diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus
AT wolkdavida diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus
AT trojanowskijohnq diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus
AT sherwinpaulf diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus
AT smithadrian diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus
AT heurlingkerstin diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus
AT sumandy diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus
AT grachevigord diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus